Mkts

Contineum Therapeutics, Inc.

NASDAQ: CTNM
$10.30+0.78 (+8.19%)
As of Nov 9, 4:00 PM ET

Key statistics

Day range
9.3210.50
52-week range
6.7217.79
Today
Open9.74
Previous close10.30
Volume794.3K
Valuation
Market cap373.81M
P/E ratio—
EPS (TTM)-1.77
Income & risk
Dividend / yield—
Beta1.03
Avg volume685.3K
Discussion

CTNM News

Stories mentioning CTNM from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue0.000.00
Cost of Goods Sold
Gross Profit0.000.000.000.000.00
Operating Expenses
Research & Development11,64812,75510,99214,06313,71213,0159,7287,901
Sales General & Admin
Total Operating Expenses16,90417,11514,93217,90218,11017,04612,97410,944
Operating Income (Loss)(16,904)(17,115)(14,932)(17,902)(18,110)(17,046)(12,974)(10,944)
Interest Income2,5052,0101,9572,0292,2502,5272,7412,001
Interest Expense
Other Expense(57.00)(51.00)183.00(167.00)(130.00)(46.00)(34.00)(77.00)
Pretax Income(14,565)(10,267)(9,009)
Tax Provision0.000.000.00
Net Income (Loss)(14,456)(15,156)(12,792)(16,040)(15,990)(14,565)(10,267)(9,009)
Earnings Per Share (Basic)(0.39)(0.55)(0.45)(0.62)(0.62)(0.75)(0.40)(0.39)
Earnings Per Share (Diluted)(0.39)(0.62)(0.75)(0.40)(0.39)
Weighted Average Shares Outstanding (Basic)37,33927,70128,11625,89625,86919,35325,73023,356
Weighted Average Shares Outstanding (Diluted)37,33925,86919,35325,73023,356

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About CTNM

Contineum Therapeutics, Inc. (NASDAQ: CTNM) is a stock listed on the Nasdaq Stock Market under the ticker symbol CTNM. It last traded at $10.30 (Nov 9, 2026, 4:00 PM ET), up 8.2% on the day. That gives Contineum Therapeutics a market capitalisation of $373.8M.

Over the past 52 weeks CTNM has traded between $6.72 and $17.79.

For the quarter ended Mar 31, 2026 it reported a net loss of $14.5M.

Last 4 quarters
Quarter endedRevenueNet income
Mar 31, 2026—-$14.5M
Dec 31, 2025—-$15.2M
Sep 30, 2025—-$12.8M
Jun 30, 2025—-$16.0M

From Contineum Therapeutics’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…